Overview
- Quantinuum sold 28 million Class A shares at $60 to raise $1.68 billion and began trading on the Nasdaq under the ticker QNT.
- The stock opened well above the IPO price but swung sharply after underwriters stepped back from aftermarket support, driving a drop from intraday highs into the mid‑$50s.
- Company filings show limited commercial revenue of about $30.9 million in 2025, a net loss near $192.6 million, and large R&D spending that underpins its development roadmap.
- Quantinuum has announced nonbinding agreements with Mitsubishi Electric and a letter of intent with the Commerce CHIPS R&D Office that could include federal funding to build larger trapped‑ion systems.
- Honeywell will retain substantial voting influence in the public company, and the IPO outcome is now serving as a price signal for other quantum firms and investors weighing sector valuation versus near‑term commercial traction.